Congestive Heart failure (CHF) is the leading cause of hospitalizations in patients over 65 years of age. About 1 in 3 patients admitted to hospital will die within one year. Early death of patients and rehospitalization and the associated costs can be reduced dramatically, when the progress of CHF is monitored.
„Measuring blood pressure inside the body is crucial for the early prediction of worsening heart failure and to the proactive management of patients. Being able to monitor and assess intra-cardiac pressure daily and in real-time, in the patient’s home could provide an early warning of potential heart decompensation by allowing for the titration of medications on the basis of reliable physiological data. This will eventually help in decreasing the chance of being admitted to the hospital with heart failure.“
The new diagnosis platform CardioWatch, propagated by the consortium, solves the major drawbacks of traditional home monitoring. Thus, the new technology holds the promise of reducing hospitalizations, improving a patient’s quality of life and delivering more efficient and cost-effective health care.
More information can be obtained from the participants web sites directly: